Quick Answer
ARTELO BIOSCIENCES, INC. reported Cash and Equivalents of $6.63 million for fiscal year 2021.
ARTELO BIOSCIENCES, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2021 | $6.63M | +209.5% |
| 2020 | $2.14M | -51.6% |
| 2019 | $4.42M | +1211.1% |
| 2018 | $337.4K | -41.1% |
| 2017 | $572.8K | +15854.7% |
| 2016 | $3.6K | -78.9% |
| 2015 | $17.0K | +15.6% |
| 2014 | $14.7K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2022 | $7.14M | — | -41.1% |
| June 30, 2022 | $12.12M | +92.1% | +17.1% |
| March 31, 2022 | $10.35M | +29.2% | -14.9% |
| December 31, 2021 | $12.16M | +110.3% | -13.4% |
| November 30, 2021 | $14.05M | +90.1% | +111.9% |
| August 31, 2021 | $6.63M | — | +5.1% |
| June 30, 2021 | $6.31M | — | -37.2% |
| May 31, 2021 | $10.05M | — | +25.4% |
- ARTELO BIOSCIENCES, INC. showed an increase of +209.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2014–2021 period, ARTELO BIOSCIENCES, INC.’s cash and equivalents has grown by 44900.3% (from $14.7 thousand to $6.63 million).
- The most recent figure is from ARTELO BIOSCIENCES, INC.’s fiscal year 2021 report (Form 10-K), filed with the SEC on November 29, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: